China’s Pharmaceutical Industry – Porter’s Five Forces Strategy Analysis

Date: February 1, 2012
Pages: 20
Price:
US$ 175.00
Publisher: Aruvian's R'search
Report type: Strategic Report
Delivery: E-mail Delivery (PDF), Hard Copy Mail Delivery, CD-ROM Mail Delivery
ID: CC6B95763AEEN
Leaflet:

Download PDF Leaflet

China’s Pharmaceutical Industry – Porter’s Five Forces Strategy Analysis
The Chinese pharmaceuticals market is forecast to become the world's firth largest by 2010 - and the largest by 2050. There are still greater market access following China's entry into the World Trade Organization (WTO), multinational investors continue to face a range of obstacles, many of which stem from the legacy of central planning of the industry. These include complex distribution, under-developed retail options, intellectual property infringements and pricing controls and pressures. At the same time, the continuing reliance of leading domestic companies on generic drugs has prevented the emergence of Chinese brands.

However, the industry is still small-scale, with a scattered geographical layout, duplicated production processes, and outdated manufacturing technology and management structure. The Chinese pharmaceutical industry also has a lower market concentration and weak international trading competitiveness, coupled with a lack of patented pharmaceuticals developed in-house.

Aruvian's R'search analyzes China’s Pharmaceutical Industry in Michael Porter’s Five Forces Analysis. It uses concepts developed in Industrial Organization (IO) economics to derive five forces that determine the competitive intensity and therefore attractiveness of a market. Porter referred to these forces as the microenvironment, to contrast it with the more general term macro-environment. They consist of those forces close to a company that affect its ability to serve its customers and make a profit. A change in any of the forces normally requires a company to re-assess the marketplace.
A. EXECUTIVE SUMMARY

B. INTRODUCTION TO THE INDUSTRY


B.1 Industry Definition
B.2 Industry Profile
B.3 Industry Segments
B.4 Future Outlook

C. PORTER’S FIVE FORCES STRATEGY ANALYSIS

C.1 Bargaining Power of Buyers
C.2 Bargaining Power of Suppliers
C.3 Competitive Rivalry in the Industry
C.4 Threat of New Entrants
C.5 Threat of Substitutes

D. CONCLUSION

E. GLOSSARY OF TERMS
Skip to top


Ask Your Question

China’s Pharmaceutical Industry – Porter’s Five Forces Strategy Analysis
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: